fenofibrate has been researched along with Myositis, Multiple in 3 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
| Excerpt | Relevance | Reference |
|---|---|---|
| "Five patients (median age 68 [54-78], female N =4) with CLD treatment (statin N =4, fenofibrates N =1) have developed iatrogenic polymyositis." | 3.72 | [Polymyositis induced or associated with lipid-lowering drugs: five cases]. ( Bataille, D; Devulder, B; Fauchais, AL; Hachulla, E; Hatron, PY; Iba Ba, J; Kyndt, X; Lambert, M; Maurage, P; Michon Pasturel, U; Parent, D; Queyrel, V; Vanhille, P, 2004) |
| "Statin monotherapy is generally well tolerated, with a low frequency of adverse events." | 2.42 | Safety of statins: focus on clinical pharmacokinetics and drug interactions. ( Bellosta, S; Corsini, A; Paoletti, R, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fauchais, AL | 1 |
| Iba Ba, J | 1 |
| Maurage, P | 1 |
| Kyndt, X | 1 |
| Bataille, D | 1 |
| Hachulla, E | 1 |
| Parent, D | 1 |
| Queyrel, V | 1 |
| Lambert, M | 1 |
| Michon Pasturel, U | 1 |
| Hatron, PY | 1 |
| Vanhille, P | 1 |
| Devulder, B | 1 |
| Bellosta, S | 1 |
| Paoletti, R | 1 |
| Corsini, A | 1 |
| Cherif, O | 1 |
| Karma, F | 1 |
| Ben Amor, G | 1 |
| Kochbati, S | 1 |
| Ben Amor, B | 1 |
| Rokbani, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Liver Injury by Statins in Coronary Heart Disease (CHD) Patients With History of Hepatitis B Virus (HBV) Infection[NCT02808299] | 600 participants (Anticipated) | Observational | 2016-12-31 | Not yet recruiting | |||
| A Multicenter Study Of Nutraceutical Drinks For Cholesterol (Evaluating Effectiveness and Tolerability)[NCT01152073] | 79 participants (Actual) | Interventional | 2009-10-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for fenofibrate and Myositis, Multiple
| Article | Year |
|---|---|
Safety of statins: focus on clinical pharmacokinetics and drug interactions.
Topics: Binding, Competitive; Biological Availability; Calcium Channel Blockers; Chemical and Drug Induced L | 2004 |
Safety of statins: focus on clinical pharmacokinetics and drug interactions.
Topics: Binding, Competitive; Biological Availability; Calcium Channel Blockers; Chemical and Drug Induced L | 2004 |
Safety of statins: focus on clinical pharmacokinetics and drug interactions.
Topics: Binding, Competitive; Biological Availability; Calcium Channel Blockers; Chemical and Drug Induced L | 2004 |
Safety of statins: focus on clinical pharmacokinetics and drug interactions.
Topics: Binding, Competitive; Biological Availability; Calcium Channel Blockers; Chemical and Drug Induced L | 2004 |
2 other studies available for fenofibrate and Myositis, Multiple
| Article | Year |
|---|---|
[Polymyositis induced or associated with lipid-lowering drugs: five cases].
Topics: Aged; Antibodies, Antinuclear; Female; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhi | 2004 |
[Hypothyroidism and muscular toxicity from fenofibrate, report of a case revealed by polymyositis].
Topics: Female; Fenofibrate; Humans; Hypolipidemic Agents; Hypothyroidism; Middle Aged; Polymyositis | 1997 |